This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
18 Dec 2015  |  Global  |  Technology Alert
Medical Imaging—Toward Deep-Rooted Cancer Cell Imaging - Medical and Diagnostic Imaging Technology
This issue profiles cancer cell imaging technologies.
$950.00 -
11 Dec 2015  |  Global  |  Technology Alert
Futuretech TechVision Opportunity Engine--Therapeutics Devices (Non-Drug) for Sleep Apnea
This issue profiles technology advances and trends for the treatment of sleep apnea.
$750.00 -
27 Nov 2015  |  Global  |  Technology Alert
Medical and Diagnostic Imaging Technology TechVision Opportunity Engine--Innovating toward Enhanced Medical Imaging Platforms
This edition profiles innovations aimed at producing enhanced medical imaging platforms.
$950.00 -
30 Oct 2015  |  Global  |  Technology Alert
Medical And Diagnostic Imaging Technology--Medical Imaging Leading the Way to Better Diagnosis
This alert profiles medical imaging technologies that enable better diagnosis.
$950.00 -
28 Sep 2015  |  Global  |  Market Research
Vital Signs The Analyst's Perspective - August 2015 Issue
This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.
$450.00 -
21 Sep 2015  |  North America  |  Market Research
Vital Signs - Review of AHRA 2015: Key Conference Takeaways and Gadolinium Based MR Contrast Agents Safety Issues
Overview of Top Themes from the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA)
A record-high attendance of 1,000 radiology directors and managers convened to the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA 2015) held this year in Las Vegas. Radiology is going through interesting times indeed. Under the coordinated care paradigm that is gradually emerging in the U.S., and with all the changes th...
$450.00 -
04 Sep 2015  |  North America  |  Market Research
Vital Signs: Automation and Application Trends Drive Growth in Sample Preparation Markets
Sample preparation remains one of the largest headaches and bottlenecks in research, but is crucial to the success of downstream applications. While the market lacks the hype and excitement other hot technologies, the sample preparation market will always be a slow and steady gainer on an already large market size. Automation and application trends...
$450.00 -
24 Jul 2015  |  Global  |  Technology Alert
Medical Device Technology Alert. Novel Blood Pumping Device to Aid Heart Failure Patients; Ultrasound Diagnostic Tool for Bone Strength Assessment; Wearable Maternal-Fetal Monitor to Improve Prenatal Health
This issue profiles a novel blood pumping device to aid heart failure patients, an ultrasound diagnostic tool for bone strength assessment, and a wearable maternal-fetal monitor to improve prenatal health.
$950.00 -
24 Jul 2015  |  Global  |  Technology Alert
Nanotech Alert. Development of a Triboelectric Nanogenerator; Biomechanical Energy Harvesting with Piezoelectric Nanogenerators; Chemotherapy Enabled by Nanoparticles Treats Cancer Stem-Like Cells
This issue profiles development of a triboelectric nanogenerator, biomechanical energy harvesting with piezoelectric nanogenerators, and chemotherapy enabled by nanoparticles treats cancer stem-like cells.
$250.00 -
24 Jul 2015  |  Global  |  Technology Alert
Genetic Technology Alert. High-Priced Hepatitis C Drug Results in Development of Generic Products; FDA-Approved Rapid Antigen Test for Ebola; Focused Antiviral Clinical Programs for Infectious Diseases
This issue profiles a high-priced hepatitis c drug that results in development of generic products, a rapid antigen test for Ebola, and focused antiviral clinical programs for infectious diseases.
$250.00